U.S. POINT-OF-CARE DIAGNOSTICS MARKET SIZE WILL CROSS USD 11 BILLION BY 2024, GROWING AT A CAGR OF 7% DURING THE FORECAST PERIOD

U.S. Point-of-care Diagnostics Market Size, Share, & Trends Analysis Report by Product (POC Analyzers and Consumables), Application (Blood Glucose Testing, Cardiovascular and Metabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drugs Of Abuse Testing, and Pregnancy And Fertility/Ovulation Testing), Usage Type (Professional POC Diagnostics and At-Home POC Diagnostics), And End-Users (Professional Healthcare Settings, Home Care, and Others) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2024

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

183 Pages

icon-table

43 Tables

icon-chart

48 Charts

icon-region

1 Regions

icon-country

1 Countries

icon-company

23 Companies

icon-market

4 Market Segment

U.S. Point-of-Care Diagnostics Market Research Scope

Report Attribute Details
MARKET SIZE (REVENUE) USD 11 BILLION (2024)
CAGR 7% (2019-2024)
Base Year 2018
Forecast Year 2019-2024
Market Segments Product (POC Analyzers and Consumables), Application (Blood Glucose Testing, Cardiovascular and Metabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drugs Of Abuse Testing, and Pregnancy And Fertility/Ovulation Testing), Usage Type (Professional POC Diagnostics and At-Home POC Diagnostics), End-Users (Professional Healthcare Settings, Home Care, and Others
Geographic Analysis North Ameica
Countries Covered The US

INDUSTRY INSIGHTS

The U.S. Point-of-Care Diagnostics market size will be valued at USD 11 billion in 2024, growing at a CAGR of 7% during 2019-2024. The dynamic changes in the healthcare industry and increasing focus on patient-centered services will propel the demand of point-of-care diagnostics in the US. The implementation of reforms and policies that enable professionals to provide cost-effective and high-quality care to patients is revolutionizing the POCT market. POC testing is emerging as an alternative diagnostic model especially for people residing in remote locations of the country. The increasing awareness about diseases and focus on early diagnosis and disease prevention is contributing to the development of the U.S. point-of-care diagnostics market. The growing popularity of homecare or self-monitoring of diseases, especially self-blood glucose monitoring is contributing to the growth of point-of-care diagnostics distribution network. The advent of remote healthcare & patient monitoring, miniaturization of diagnostic devices, wearable medical devices, and growing usage of smartphones for healthcare applications are some of the key factors contributing to the revenues. The growing popularity of self-testing modules and growth of the in-vitro diagnostics industry will create lucrative opportunities for the leading vendors. The rise in the number of rapid-onset and life-threatening conditions such as sepsis and acute cardiac infarction and will boost demand for POC systems. The ability of POCTs to deliver immediate results thus providing improved patient care will improve, deliver faster and accurate results. This system will also increase the penetration of EMR/HER, remote patient monitoring, self-testing and telehealth . The increasing awareness about disease management and self-monitoring will drive market revenues.

The emergence of wearable medical devices, lab-on-a-chip technology, and growing usage of smartphones is driving the demand for point-of-care devices. The growing availability of rapid tests for diagnosing infectious diseases like HIV, TB or malaria, that enable physicians and patients to visualize the results from a smartphone and take appropriate clinical decisions will transform the market over the next few years.

MARKET TRENDS

The recent development of microfluidic-based POC devices will transform the U.S. point-of-care diagnostics market during the forecast period. The rising application of microfluidic technologies to develop and commercialize advanced clinical diagnostic analyzers will lead to the launch of innovative POC systems. Some of the most commonly used microfluidics-based analyzers are blood chemistries, nucleic-acid amplification tests, immunoassays, and flow cytometry. This process used the ability to extensive use of complex multiplexing approaches and formats, the capacity for inclusion of sequential sample pre-conditioning steps of different types, reagent storage, the use of multiple steps involving reagent addition, mixing and washing, the potential for incorporation of centrifugal steps at various speeds, and the application of a range of detection strategies leading to greater sensitivity and clarity of results. The growing use of POC systems in ambulatory care and physician offices for accurate clinical decision making will contribute to the profitability in the market.

U.S. POINT-OF-CARE DIAGNOSTICS MARKET SEGMENTATION

This market research report includes detailed market segmentation by

  • Product
  • Application
  • End-user

INSIGHTS BY PRODUCT

Consumables segment dominated more than half of the total share in 2018, growing at a CAGR of approximately 8% during the forecast period. The increasing use of various rapid tests across emergency care, physician offices, ambulatory settings, nursing homes, and by individuals for diagnosing various diseases is propelling the growth of this segment. The rapid tests are used for diagnosing diseases such as infectious diseases, diabetes, cancer, and other metabolic diseases. The vendors are offering a diverse range of consumables catering to end-user requirements and that are patient-center approaches to gain the maximum consumers. Some of the most common POC consumables available in the U.S. point-of-care diagnostics market are reagents, immunodiagnostic test kits, blood glucose test strips, and pregnancy and fertility test kits.

The growing incidences of various acute and chronic diseases such as cardiovascular diseases, hepatitis, HIV, cancer, chronic kidney disease, diabetes, and sexually transmitted diseases (STDs) is boosting the demand for POC analyzers. The introduction of automated and compact POC analyzers that help improve the efficiency and quality of the operations will drive the demand for these devices in the U.S. point-of-care diagnostics market.

INSIGHTS BY APPLICATION

The application segment in the U.S. point-of-care diagnostics market is classified into blood glucose testing, cardiovascular and metabolic testing, infectious disease testing, blood coagulation testing, hematology testing, cancer testing, drugs of abuse testing, and pregnancy and fertility/ovulation testing. Infectious disease testing is the fastest growing technology segment, at a CAGR of around 11% during the forecast period. The launch of POC diagnostics and rapid test kits providing accurate and quick diagnostics is propelling the growth of this segment. The use of these rapid tests will help reduce the use of unnecessary antibiotics and result in the cost-effective and quick decision-making process in the market. Leading point-of-care diagnostics companies such as Roche Diagnostics is offering advanced POC analyzers for infectious disease testing and boosting the demand in the U.S. point-of-care diagnostics market.

The rapid adoption of various self-testing blood glucose devices that offer portability and convenience will augment the development of the US market. The growing demand for POC cardiometabolic testing will enable easy disease management and monitor cardiometabolic conditions such as cardiac markers, lipid analysis, blood gases, HbA1C, and cholesterol levels on a real-time basis. The vendors are introducing a broad range of rapid test for cancer screening and detection for reliable, fast, and non-invasive tests to gain larger shares.

INSIGHTS BY END-USER

The professional healthcare segment occupied more than half of the total share in 2018, growing at a CAGR of around 7% during the forecast period. The increasing use of point-of-care diagnostics technology for detecting of acute and chronic diseases is fueling the growth of this segment. The increasing incidences of chronic illnesses, such as diabetes, HIV, cancer, and heart diseases and acute diseases like sepsis, respiratory tract infections (RTIs), and antibiotic resistance is driving the demand for these services. The increasing use of medical diagnosis, biosensors, and point-of-care testing devices is augmenting the development of this segment. The government initiatives aimed to promote the use of point-of-care diagnostic tests will boost revenues over the next few years.

The increasing use of self-monitoring devices and test kits as an early symptom management tool and to manage high-risk chronically ill patients will drive the growth of the home care segment. These test kits also find applications across the academic and research institutes, military, and non-profit organizations in the U.S. point-of-care diagnostics market.

INSIGHTS BY USAGE

At-home POC diagnostic is the fastest growing segment, at a CAGR of more than 7% during the forecast period. The cost-effective and quick results of this procedure are augmenting the growth of this segment. The increasing availability of self-testing kits available for diagnosing UTIs and other acute infections, assess fertility by way of ovarian egg reserve, and check for STDs is contributing to the development of the at-home care setup. These tests are designed to offer quick, cost-effective, and confidential information at the convenience of the patient’s home. The increasing awareness about the self-testing and screening kits will contribute to the major revenues.

The professional healthcare setup consists of physician office labs, clinics, emergency care centers, critical care in hospitals, nursing homes, community care centers, home care centers like geriatric and pediatric care centers. The increasing launch of many innovative and compact POC analyzers and the rapid test will contribute to the growing revenues in the U.S. point-of-care diagnostics market shares.

KEY VENDOR ANALYSIS

The market is highly dynamic due to the presence of several international and regional players operating in the region. The vendors are offering a diverse range of analyzers and kits to attract the maximum number of consumers in the US market. Strategical partnerships and consolidation will positively impact the development of the competitive landscape in the US. Effective strategies such as the expansion of product offerings, accessing new technology, and increasing share will help companies survive the intense competition in the market.

Major vendors:

  • Abbott
  •  F. Hoffmann-La Roche
  • Siemens Healthineers

The U.S. point-of-care diagnostics market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

By Product

  • POC Analyzers
  • Consumables

By Application

  • Blood Glucose Testing
  • Cardiovascular and Metabolic Testing
  • Infectious Disease Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drugs of Abuse Testing
  • Pregnancy and Fertility/Ovulation Testing

By Usage

  • Professional POC Diagnostics
  • At-Home POC Diagnostics

By End-users

  • Professional Healthcare Settings
  • Home Care
  • Others

Frequently Asked Questions

What is the U.S. point-of-care diagnostics market size and growth rate during the forecast period?

U.S. POINT-OF-CARE DIAGNOSTICS MARKET SIZE WILL REACH USD 11 BILLION BY 2024, GROWING AT A CAGR OF 7% DURING 2019-2024

What are the factors impacting the growth of the U.S. point-of-care diagnostics market shares?

The US point-of-care diagnostics market is driven by the latest innovations in the diagnostics industry is to provide an expedited diagnosis for quick clinical decision making to support treatment regimens.

Which product/application/end-user is generating the largest revenues for the U.S. market?

The consumables segment dominated more than half of the total share in 2018, growing at a CAGR of approximately 8% during the forecast period.

Who are the leading vendors in the U.S. point-of-care diagnostics market, and what are their market shares?

The leading vendors in the US POC diagnostic market are Abbott, F. Hoffmann-La Roche, and Siemens Healthineers

How is the growth of the healthcare settings segment influencing the growth of the U.S. point-of-care diagnostics market trends and growth drivers?

At-home POC diagnostic is the fastest-growing segment, at a CAGR of more than 7% during the forecast period. The cost-effective and quick results of this procedure are augmenting the growth of this segment.

Download Free Sample

The US point-of-care diagnostics market size is expected to reach revenues of approximately $11 billion by 2024, growing at a CAGR of over 7% 2019–2024.

The US point-of-care diagnostics market is driven by the latest innovations in diagnostics industry is to provide an expedited diagnosis for quick clinical decision making to support treatment regimens. The growing need to deliver quantitative lab-quality results and transfer to an information system, or a healthcare professional, or store as an electronic medical record for future analysis and interpretation will drive the demand for new technologies in the US point-of-care diagnostics market. The market research report provides in-depth market analysis and segmental analysis of the US point-of-care diagnostics market by product, technology, usage type, and end-users.

Base Year:                  2018

Forecast Year:           2019–2024

The report considers the present scenario of the US point-of-care diagnostics market and its market dynamics for the period 2019−2024. It covers a detailed overview of various market growth enablers, restraints, and trends. The report segments the market based on the product type (POC analyzers and consumables); application type (blood glucose testing, cardiovascular and metabolic testing, infectious disease testing, blood coagulation testing, hematology testing, cancer testing, drugs of abuse testing, and pregnancy and fertility/ovulation testing); usage type (professional POC diagnostics and at-home POC diagnostics) and end-user type (professional healthcare settings, home care, and others), while elaborating the present market scenario and discussing the futuristic demand in the market for POC diagnostics. It also profiles and analyzes the leading companies and various other prominent companies operating in the market. The report also discusses the future market growth, improvement areas, and strategic recommendations for the US point-of-care diagnostics market vendors.

Major Vendors in the US Point-of-Care Diagnostics Market

  • Abbott
    • Business Overview
    • Abbott in the US Market
    • Major Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  •   F. Hoffmann-La Roche
  • Siemens Healthineers

Key companies to Watch in the US Point-of-Care Diagnostics Market

  • Danaher     
    • Business Overview
    • Danaher in the US Market
    • Major Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • LifeScan
  • Ascensia Diabetes Care Holdings
  • Quidel
  • BD

Prominent Players in the US Point-of-Care Diagnostics Market

  • Abaxis
    • Business Overview
    • Product Offerings
  • Acon Laboratories
  • AgaMatrix
  • Arbor Vita
  • bioMérieux
  • Chembio Diagnostic Systems
  • EKF Diagnostics USA
  • Exact Sciences
  • Instrumentation Laboratory
  • Meridian Bioscience
  • Sekisui Diagnostics
  • Sinocare
  • Sysmex America
  • Swiss Precision Diagnostics

Market Segmentation by Product

  • POC Analyzers
  • Consumables

Market Segmentation by Application

  • Blood Glucose Testing
  • Cardiovascular and Metabolic Testing
  • Infectious Disease Testing
  • Blood Coagulation Testing
  • Hematology Testing
  • Cancer Testing
  • Drugs of Abuse Testing
  • Pregnancy and Fertility/Ovulation Testing

Market Segmentation by Usage

  • Professional POC Diagnostics
  • At-Home POC Diagnostics

Market Segmentation by End-users

  • Professional Healthcare Settings
  • Home Care
  • Others

1 Research Methodology

2 Research Objectives

3 Research Process

4 Report Coverage

4.1 Market Definition

4.2 Base Year

4.3 Scope of Study

4.3.1 US Point-of-care Diagnostics Market Segmentation by Product Types

4.3.2 US Point-of-care Diagnostics Market Segmentation by Application Types

4.3.3 US Point-of-care Diagnostics Market Segmentation by Usage

4.3.4 US Point-of-care Diagnostics Market Segmentation by End-user Types

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Inclusions

5.3 Exclusions

5.4 Currency Conversion

5.5 Market Derivation

6 Market at a Glance

7 Introduction

7.1 POC: An Overview

8 Market Dynamics

8.1 US Point-of-care Diagnostics Market Growth Enablers

8.1.1 Increase in Prevalence/Incidence of Several Acute and Chronic Diseases

8.1.2 New Product Approvals/Launches

8.1.3 Increasing Number of CLIA Waiver POC Tests

8.1.4 High Focus on Early Diagnosis and Disease Prevention

8.1.5 Vendors’ Focus on Manufacturing Innovative POC Platforms for Existing and New Applications

8.1.6 YOY Impact of Market Growth Enablers

8.2 US Point-of-care Diagnostics Market Growth Restraints

8.2.1 Time Consuming and Stringent Regulations for Approvals of POC Diagnostics

8.2.2 Limitations and Data Accuracy Challenges with POC Diagnostics

8.2.3 YOY Impact of Market Growth Restraints

8.3 US Point-of-care Diagnostics Market Opportunities & Trends

8.3.1 Growing Demand for POC Molecular Diagnostic Testing

8.3.2 High Growth Potential for Multiplexed POC Diagnostic Testing (xPOCT)

8.3.3 Strategic Acquisitions

8.3.4 Robust Pipeline and Investigational POC Diagnostic Devices

8.3.5 Development of Microfluidic-based POC devices

8.3.6 YOY Impact of Market Opportunities & Trends

9 US Point-of-care Diagnostics Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Porter’s Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 US Point-of-care Diagnostics Market by Product

10.1 Market Overview

10.2 Consumables

10.2.1 Market Overview

10.2.2 Market Size & Forecast

10.3 POC Analyzers/Instruments

10.3.1 Market Overview

10.3.2 Market Size & Forecast

11 US Point-of-care Diagnostics Market by Application

11.1 Market Overview

11.2 Blood Glucose Testing

11.2.1 Market Overview

11.2.2 Market Size & Forecast

11.3 Cardiovascular and Metabolic Testing

11.3.1 Market Overview

11.3.2 Market Size & Forecast

11.4 Infectious Disease Testing

11.4.1 Market Overview

11.4.2 Market Size & Forecast

11.5 POC Blood Coagulation Testing

11.5.1 Market Overview

11.5.2 Market Size & Forecast

11.6 POC Hematology Testing

11.6.1 Market Size & Forecast

11.7 POC Cancer Testing

11.7.1 Market Overview

11.7.2 Market Size & Forecast

11.8 POC Drugs of Abuse Testing

11.8.1 Market Size & Forecast

11.9 Pregnancy and Fertility/Ovulation Testing

11.9.1 Market Size & Forecast

12 US Point-of-care Diagnostics Market by End-user

12.1 Market Overview

12.2 Professional Healthcare Settings

12.2.1 Market Overview

12.2.2 Professional Healthcare Settings: Market Size & Forecast

12.2.3 Hospitals and Laboratories: Market Size & Forecast

12.2.4 Ambulatory Care Settings: Market Size & Forecast

12.2.5 Emergency Care/Urgent Care Centers: Market Size & Forecast

12.3 Home Care

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.4 Other End-users

12.4.1 Market Size & Forecast

13 US Point-of-care Diagnostics Market by Prescription

13.1 Market Overview

13.2 Professional POC Diagnostics

13.2.1 Market Size & Forecast

13.3 At-home/OTC-based POC

13.3.1 Market Size & Forecast

14 Competitive Landscape

14.1 Market overview

14.2 Market Vendor Share/Ranking Analysis

15 Key Company Profiles

15.1 Abbott

15.1.1 Business Overview

15.1.2 Abbott in US Point-of-care Diagnostics Market

15.1.3 Major Product Offerings

15.1.4 Key Strategies

15.1.5 Key Strengths

15.1.6 Key Opportunities

15.2 F. Hoffmann-La Roche

15.2.1 Business Overview

15.2.2 F. Hoffmann-La Roche in US Point-of-care Diagnostics Market

15.2.3 Major Product Offerings

15.2.4 Key Strategies

15.2.5 Key Strengths

15.2.6 Key Opportunities

15.3 Siemens Healthineers

15.3.1 Business Overview

15.3.2 Siemens Healthineers in US Point-of-care Diagnostics Market

15.3.3 Major Product Offerings

15.3.4 Key Strategies

15.3.5 Key Strengths

15.3.6 Key Opportunities

16 Key Companies to Watch

16.1 Danaher

16.1.1 Business Overview

16.1.2 Danaher in US Point-of-care Diagnostics Market

16.1.3 Product Offerings

16.1.4 Key Strategies

16.1.5 Key Strengths

16.1.6 Key Opportunities

16.2 LifeScan

16.2.1 Business Overview

16.2.2 Product Offerings

16.2.3 Key Strategies

16.2.4 Key Strengths

16.2.5 Key Opportunities

16.3 Ascensia Diabetes Care Holdings

16.3.1 Business Overview

16.3.2 Product Offerings

16.3.3 Key Strategies

16.3.4 Key Strengths

16.3.5 Key Opportunities

16.4 BD

16.4.1 Business Overview

16.4.2 BD in US Point-of-care Diagnostics Market

16.4.3 Product Offerings

16.4.4 Key Strategies

16.4.5 Key Strengths

16.4.6 Key Opportunities

16.5 Quidel

16.5.1 Business Overview

16.5.2 Quidel in US Point-of-care Diagnostics Market

16.5.3 Product Offerings

16.5.4 Key Strategies

16.5.5 Key Strengths

16.5.6 Key Opportunities

17 Other Prominent Vendors

17.1 Abaxis

17.1.1 Business Overview

17.1.2 Product Offerings

17.2 ACON Laboratories

17.2.1 Business Overview

17.2.2 Product Offerings

17.3 AgaMatrix

17.3.1 Business Overview

17.3.2 Product Offerings

17.4 Arbor Vita

17.4.1 Business Overview

17.4.2 Product Offerings

17.5 bioMérieux

17.5.1 Business Overview

17.5.2 Product Offerings

17.6 Chembio Diagnostic Systems

17.6.1 Business Overview

17.6.2 Product Offerings

17.7 EKF Diagnostics USA (Stanbio Laboratory)

17.7.1 Business Overview

17.7.2 Product Offerings

17.8 Exact Sciences

17.8.1 Business Overview

17.8.2 Product Offerings

17.9 Instrumentation Laboratory

17.9.1 Business Overview

17.9.2 Product Offerings

17.10 Meridian Bioscience

17.10.1 Business Overview

17.10.2Product Offerings

17.11 Sekisui Diagnostics

17.11.1 Business Overview

17.11.2Product Offerings

17.12 Sinocare

17.12.1 Business Overview

17.12.2Product Offerings

17.13 Sysmex America

17.13.1 Business Overview

17.13.2Product Offerings

17.14 Swiss Precision Diagnostics

17.14.1 Business Overview

17.14.2Product Offerings

17.15 Trinity Biotech

17.15.1 Business Overview

17.15.2Product Offerings

18 Report Summary

18.1 Key Takeaways

18.2 Strategic Recommendations

18.3 Qualitative Summary

18.4 Quantitative Summary

18.4.1 Market by Application

18.4.2 Market by Product

18.4.3 Market by Usage Type

18.4.4 Market by End-users

19 Appendix

19.1 Abbreviations

List of Exhibits

Exhibit 1         Segmentation of US Point-of-care Diagnostics Market

Exhibit 2         Market Size Calculation Approach 2018

Exhibit 3         Diagnosis Steps Involved in Non-waived and CLIA-waived Diagnostic Testing

Exhibit 4         Advantages of Early Diagnosis and Prevention

Exhibit 5         Major POC Diagnostic Testing Limitations

Exhibit 6         Common Errors in POC Diagnostic Tests

Exhibit 7         US Point-of-care Diagnostics Market 2018–2024 ($ million)

Exhibit 8         Five Forces Analysis 2017

Exhibit 9         US Market by Product Type

Exhibit 10       US Market 2018 and 2024 (%)

Exhibit 11       US Point-of-care Diagnostics Market 2018−2024 ($ million)

Exhibit 12       US Market by POC Test Kits/Consumables 2018–2024 ($ million)

Exhibit 13       US Market by Analyzers/Instruments 2018–2024

Exhibit 14       US Market by Application Type

Exhibit 15       US Point-of-care Diagnostics Market by Application 2018 and 2024 (%)

Exhibit 16       US Market by Application 2018−2024 ($ million)

Exhibit 17       US Market by Blood Glucose Testing 2018–2024 ($ million)

Exhibit 18       US Market by Cardiometabolic Testing 2018–2024 ($ million)

Exhibit 19       US Market by Infectious Disease Testing 2018–2024 ($ million)

Exhibit 20       US Point-of-care Diagnostics Market by Blood Coagulation Testing 2018–2024 ($ million)

Exhibit 21       US Market by Hematology 2018–2024 ($ million)

Exhibit 22       US Market by Cancer Testing 2018–2024 ($ million)

Exhibit 23       US Point-of-care Diagnostics Market by Drugs of Abuse Testing 2018–2024 ($ million)

Exhibit 24       US Market by Pregnancy and Fertility/Ovulation Testing 2018–2024 ($ million)

Exhibit 25       US Market by End-user

Exhibit 26       US Market 2018 and 2024 (%)

Exhibit 27       US Point-of-care Diagnostics Market by End-user 2018−2024 ($ million)

Exhibit 28       US Market by Professional Healthcare Settings 2018 (%)

Exhibit 29       US Market by Professional Healthcare Settings 2018−2024 ($ million)

Exhibit 30       US Market by Professional Healthcare Settings 2018−2024 (%)

Exhibit 31       US Market by Professional Healthcare Settings 2018–2024 ($ million)

Exhibit 32       US Market by Hospitals and Laboratories 2018–2024 ($ million)

Exhibit 33       US Market by Ambulatory Care Settings 2018–2024 ($ million)

Exhibit 34       US Market by Emergency Care/Urgent Care Centers 2018–2024 ($ million)

Exhibit 35       US Market by Home Care 2018–2024 ($ million)

Exhibit 36       US Market by Other End-users 2018–2024 ($ million)

Exhibit 37       US Market by Usage Type

Exhibit 38       US Market by Usage Type 2018 & 2024 (%)

Exhibit 39       US Market by Usage Type 2018−2024 ($ million)

Exhibit 40       US Point-of-care Diagnostics Market by Usage Type 2018−2024 (%)

Exhibit 41       Prescription-based US Point-of-care Diagnostics Market 2018−2024 ($ million)

Exhibit 42       At-home/OTC-based US Point-of-care Diagnostics Market 2018−2024 ($ million)

Exhibit 43       Abbott Sales Breakdown by Segments 2017

Exhibit 44       F. Hoffmann-La Roche Sales Breakdown by Divisions 2017

Exhibit 45       Siemens Healthineers Revenue Breakdown by Business Segments 2017 (%)

Exhibit 46       Danaher Sales Breakdown by Business Segments 2017 (%)

Exhibit 47       Danaher Business Segments R&D Expenditure 2017 (%)

Exhibit 48       Quidel Revenue Breakdown by Product Categories 2017 (%)

           

List of Tables          

Table 1            Key Caveats

Table 2            Currency Conversion 2013−2017

Table 3            Recent Product Approvals in US Point-of-care Diagnostics Market

Table 4            Tests Granted CLIA-waived Status by CMS and their CPT Codes Recently

Table 5            Few Popular Innovative POC Diagnostics Available in US

Table 6            YOY Impact of Market Growth Enablers 2018−2024

Table 7            YOY Impact of Market Growth Restraints 2018−2024

Table 8            Popular POC Molecular Diagnostics and Tests in US

Table 9            xPOCT Systems Available in US

Table 10         Recent Acquisitions in Point-of-care Diagnostics Market

Table 11         US Point-of-care Diagnostics Market: Pipeline Devices and Tests

Table 12         Microfluidic-based POC Devices Under Investigation

Table 13         YOY Impact of Market Opportunities & Trends 2018−2024

Table 14         Popular Blood Glucose Meter Brands in US

Table 15         US Point-of-care Diagnostics Market: Vendors Ranking

Table 16         Abbott: Product Offerings

Table 17         F. Hoffmann-La Roche: Product Offerings

Table 18         Siemens Healthineers: Product Offerings

Table 19         Danaher: Product Offerings

Table 20         LifeScan: Product Offerings

Table 21         Ascensia Diabetes Care: Product Offerings

Table 22         BD: Product Offerings

Table 23         Quidel: Product Offerings

Table 24         Abaxis: Product Offerings

Table 25         ACON Laboratories: Product Offerings

Table 26         AgaMatrix: Product Offerings

Table 27         Arbor Vita: Product Offerings

Table 28         bioMérieux: Product Offerings

Table 29         Chembio Diagnostic Systems: Product Offerings

Table 30         EKF Diagnostics: Product Offering

Table 31         Exact Sciences: Product Offerings

Table 32         Instrumentation Laboratory: Major Product Offerings

Table 33         Meridian Bioscience: Product Offerings

Table 34         Sekisui Diagnostics: Product Offerings

Table 35         Sinocare: Product Offerings

Table 36         Sysmex America: Product Offerings

Table 37         Swiss Precision Diagnostics: Product Offerings

Table 38         Trinity Biotech: Product Offerings

Table 39         Qualitative Summary of US Point-of-care Diagnostics Market

Table 40         US Market by Application 2018–2024

Table 41         US Market by Product Types 2018–2024

Table 42         US Market by Prescription Types 2018–2024

Table 43         US Point-of-care Diagnostics Market by End-user 2018–2024

Select a license type that suits your business needs

single-user Single User Licence
$4250.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4500.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5500.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date